Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    CMO Excellence in Green Chemistry Award

    CMO Excellence in Green Chemistry Award supports contract manufacturing organizations by recognizing pharmaceutical chemistry advances that improve environmental performance, safety, or efficiency at scale.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: American Chemical Society

    Due Dates: October 1, 2026 (Applications open) | December 1, 2026 (Application deadline)

    Funding Amounts: Award listed at up to $5,000; conference travel reimbursement up to $2,500, with additional international travel funds available

    Summary: Recognizes contract manufacturing organizations for pharmaceutical green chemistry advances demonstrating environmental, safety, or efficiency improvements at meaningful scale.

    Key Information: Open to CMOs worldwide; ACS or ACS GCIPR membership is not required.


    Description

    The ACS Green Chemistry Institute Pharmaceutical Roundtable (GCIPR) created this award to recognize company-level achievements by Contract Manufacturing Organizations (CMOs) supporting pharmaceutical research, development, and manufacturing. It recognizes greener synthetic routes for starting materials, intermediates, and active pharmaceutical ingredients, as well as improvements in reaction conditions and chemical or manufacturing technologies.

    Nominations should demonstrate green chemistry accomplishments at meaningful scale and explain their significance. Relevant improvements include reduced process mass intensity, improved greenness metrics, waste reduction, greater robustness, lower environmental, health, and safety impacts, and reduced use of toxic or hazardous chemicals, solvents, and reagents. The award emphasizes a strategic company commitment to green chemistry and engineering innovation and greater industrial sustainability.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.